article thumbnail

Roquette opens pharmaceutical innovation facility in Pennsylvania, US

Pharmaceutical Technology

The facility complements the company’s current pharma innovation centres in France and Singapore, and intends to improve the patient experience with modern oral dosage forms. It also aims to contribute to the pharmaceutical sector by facilitating cross-industry partnerships and research-based product development.

Dosage 52
article thumbnail

News on FDA’s Quality Management Maturity Program-Maturity to Continually Improve and to not be Reactive

The FDA Law Blog

The lessons learned were also discussed during a November 2022 workshop hosted by the FDA. FDA published two Federal Register Notices in October 2020 to recruit domestic drug product manufacturers of finished dosage forms and foreign manufacturers of active pharmaceutical ingredients to participate in the QMM Pilot Programs.

FDA 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advancements & Innovations in Decontamination and Single-Use Technology

ISPE

The second day’s keynote will feature Emily Craven from Boston Scientific and focus on the growing opportunity to optimize sterilization technology for active pharmaceutical ingredients (API) that is used to formulate sterile dosage forms and how the current supply chain constraints will welcome innovation in this area.

Dosage 52
article thumbnail

Semaglutide and Tirzepatide Resources for Independent Pharmacies

DiversifyRx

There will be variations in dosing and efficacy across all these dosage forms. For many patients, lower dosages work well at reducing appetite and increasing fullness. If you want a full training on how to legally and efficiently add peptide compounding to your pharmacy, check out our Peptide Compounding Mastery Workshop.

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

A final report will be provided as the basis for an ISPE workshop, with recommendations subsequently published in Pharmaceutical Engineering and other trade publications. Case studies will be developed from the survey feedback with proposed solutions, which should support engagement with regulatory authorities globally.

FDA 52
article thumbnail

Removing Regulatory Hurdles for Continuous Pharmaceutical Manufacturing

ISPE

In addition to the FDA, health authorities in Canada, Europe, Australia, Japan, Switzerland, and New Zealand have also approved applications with CM for the production of solid oral dosage forms. End-to-end continuous processes flow from starting materials to finished dosage forms. Updated 19 April 2016. 4 a b Byrn, S., Jayjock, N.

FDA 52
article thumbnail

Aseptic Conference Provides Solutions to Pharmaceutical Challenges

ISPE

Blow-fill-seal containers are commonly used for various dosage forms, what are the latest developments in this field? In addition to the topical tracks, there will also be workshop-type discussion groups where you can directly interact with your fellow participants and ask your questions in an open forum.

Dosage 98